Shypd.aiThe largest open index of AI tools
Verge Genomics is a Pharma & Biotech tool that uses an all-in-human AI-powered drug discovery platform. It aims to develop better drugs faster by leveraging human genomics and machine learning.
Trending
Also listed in
About
Verge Genomics has pioneered an advanced all-in-human AI-powered drug discovery platform, focusing on developing new drugs for major medical challenges. The platform leverages human genomics, machine learning, biological engineering, and translational medicine to decipher disease biology. Instead of relying on animal or cell models, Verge Genomics utilizes one of the world's largest proprietary multi-omics databases derived directly from human tissue. This approach allows them to map complex disease causes and develop proprietary drug candidates. Their first drug, VRG50635, for amyotrophic lateral sclerosis (ALS), moved from research to clinic in just four years, demonstrating the platform's efficiency. They are also working on treatments for Parkinson's Disease and Frontotemporal Dementia.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check vergegenomics.com for current pricing.
FAQs
Trending
